Skip to main navigation Skip to search Skip to main content

Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia

  • Eunice S. Wang
  • , Amer Zeidan
  • , Wei Tan
  • , Gregory E. Wilding
  • , Laurie Ann Ford
  • , Paul K. Wallace
  • , Theresa E. Hahn
  • , Minoo Battiwalla
  • , Philip L. McCarthy
  • , Meir Wetzler
  • Roswell Park Cancer Institute
  • Rochester General Hospital
  • Johns Hopkins University
  • Department of Biostatistics
  • Flow Cytometry Facility

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish
Pages (from-to)2085-2088
Number of pages4
JournalLeukemia and Lymphoma
Volume53
Issue number10
DOIs
StatePublished - Oct 2012

Fingerprint

Dive into the research topics of 'Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this